SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 375.57 |
Enterprise Value ($M) | 336.07 |
Book Value ($M) | 71.00 |
Book Value / Share | 1.19 |
Price / Book | 5.29 |
NCAV ($M) | 70.47 |
NCAV / Share | 1.18 |
Price / NCAV | 5.33 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.65 |
Return on Assets (ROA) | -0.38 |
Return on Equity (ROE) | -0.47 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.59 |
Current Ratio | 5.59 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 104.07 |
Assets | 104.61 |
Liabilities | 33.60 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -60.12 |
Net Income | -55.85 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -43.21 |
Cash from Investing | -44.92 |
Cash from Financing | -0.17 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Perceptive Advisors Llc | 15.60 | 7.94 | |
13G | Vanguard Group Inc | 6.68 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
98,488 | 534,317 | 18.43 | |
86,266 | 446,349 | 19.33 | |
98,674 | 455,748 | 21.65 | |
147,628 | 857,269 | 17.22 | |
(click for more detail) |
Similar Companies | |
---|---|
AKAN – Akanda Corp. | AKBA – Akebia Therapeutics, Inc. |
ALBT – Avalon GloboCare Corp. | ALGS – Aligos Therapeutics, Inc. |
ALTS – JanOne Inc. |
Financial data and stock pages provided by
Fintel.io